Australia markets closed

Laurus Labs Limited (LAURUSLABS.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
430.00-2.85 (-0.66%)
At close: 03:30PM IST

Laurus Labs Limited

Serene Chambers
2nd Floor Road No. 7 Banjara Hills
Hyderabad 500034
India
91 40 3980 4333
https://www.lauruslabs.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees6,007

Key executives

NameTitlePayExercisedYear born
Dr. Satyanarayana Chava M.Sc., Ph.D.CEO & Whole Time Director134.71MN/A1961
Mr. Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A.CFO & Whole-Time Director43.81MN/A1965
Mr. B. V. R. K. Suryadevara Srinivasa RaoExecutive Vice President of Manufacturing & OperationsN/AN/A1968
Mr. Martyn Oliver-James PeckExecutive Vice President of Business DevelopmentN/AN/AN/A
Ch. Venkata Ramana RaoSenior Vice President of Intellectual Property ManagementN/AN/A1971
Dr. Vasireddi Uma Maheswer RaoExecutive Vice President of Chemical R&DN/AN/A1961
Mr. Thomas VersoskyPresident of FDF - North AmericaN/AN/AN/A
Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Corporate governance

Laurus Labs Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.